This PPG is concerned with increasing knowledge of the biophysics and molecular biology of urolithiasis. Project 1 deals with physical chemical problems relevant to urolithiasis, primarily of calcium oxalate and especially its surface chemistry. Also, an oxalate carboylase to be used to develop an antistone therapy will be characterized in detail. Project 2 will develop an improved understanding of the cause of idiopathic renal calculi by determining the composition of the major urinary inhibitor of calcium availability for crystal formation. Project 3 will investigate specific processes which form a scenario of the detailed mechanism of urolithiasis. Studied will be the roles played by (1) degradation products from cellular injury, (2) phospholipids from urine and from stone matrix and (3) renal tubular injury products that interfere with crystallization inhibitory activity. Project 4 will continue efforts to prevent calcium oxalate encrustation on medical devices used in the urinary tract and explore the development of an implantable immobilized oxidase system for lowering system oxalate and reducing stone-forming potential. Project 5 will explore an antistone therapy through development of a method for expression in a mammalian system of an oxylase gene from Oxalabacter formigenes via the hematopoietic system. Project 6 will characterize and model the fracture of urinary stones by extracorporeal shockwave lithotripsy in order to determine the most important parameters affecting the fracture process. Core A will provide a quantitative analysis service for a wide range of chemical substances found in urines generated by Projects 1,2,3,4 and 5. Core B will provide particle characterization services to Projects 1,3 and 6. Computer services including data reduction, analysis, computer graphics and software development will be provided to all projects as required. Development and use of models of particle production, evolution and transport in the renal system will be continued. Core C will provide budget administration for the entire program project, coordinate activities among projects and between projects and the host institution and other required administrative and secretarial services.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK020586-15
Application #
3095236
Study Section
Special Emphasis Panel (SRC (02))
Project Start
1977-09-01
Project End
1992-08-31
Budget Start
1991-09-01
Budget End
1992-08-31
Support Year
15
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Thamilselvan, S; Hackett, R L; Khan, S R (1999) Cells of proximal and distal tubular origin respond differently to challenges of oxalate and calcium oxalate crystals. J Am Soc Nephrol 10 Suppl 14:S452-6
Iida, S; Peck, A B; Johnson-Tardieu, J et al. (1999) Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis. J Am Soc Nephrol 10:986-96
Sidhu, H; Holmes, R P; Allison, M J et al. (1999) Direct quantification of the enteric bacterium Oxalobacter formigenes in human fecal samples by quantitative competitive-template PCR. J Clin Microbiol 37:1503-9
Atmani, F; Khan, S R (1999) Role of inter-alpha-inhibitor and its related proteins in urolithiasis. Purification of an inter-alpha-inhibitor related protein from the bovine kidney. Urol Res 27:57-61
Atmani, F; Glenton, P A; Khan, S R (1999) Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney. Urol Res 27:63-7
Sidhu, H; Schmidt, M E; Cornelius, J G et al. (1999) Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 10 Suppl 14:S334-40
Thamilselvan, S; Khan, S R (1998) Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies. J Nephrol 11 Suppl 1:66-9
Atmani, F; Glenton, P A; Khan, S R (1998) Identification of proteins extracted from calcium oxalate and calcium phosphate crystals induced in the urine of healthy and stone forming subjects. Urol Res 26:201-7
Sidhu, H; Allison, M; Peck, A B (1997) Identification and classification of Oxalobacter formigenes strains by using oligonucleotide probes and primers. J Clin Microbiol 35:350-3
Khan, S R (1997) Animal models of kidney stone formation: an analysis. World J Urol 15:236-43

Showing the most recent 10 out of 51 publications